We'll examine a selection from our screener results. Overview: Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for musculoskeletal disorders ...

How Do Unusual Items Influence Profit? To properly understand Globus Medical's profit results, we need to consider the US$200m expense attributed to unusual items. While deductions due to unusual ...

AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share ...

Globus Medical, Inc. has announced a share repurchase program authorized by its Board of Directors, allowing the company to buy back up to $500 million of its outstanding common stock. Chief ...

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED).

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

From new partnerships and launches, here are six developments from Globus Medical so far in 2025. 1. OsteoCentric Technologies entered into a non-exclusive licensing agreement with Globus Medical.

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 million. The repurchase includes the Audobon, Pennsylvania-based ...